{"id":1446,"date":"2020-06-22T21:42:10","date_gmt":"2020-06-22T21:42:10","guid":{"rendered":"https:\/\/grail.wpengine.com\/?post_type=press-release&p=1446"},"modified":"2021-01-12T17:57:23","modified_gmt":"2021-01-12T17:57:23","slug":"grail-to-present-new-data-supporting-its-multi-cancer-early-detection-test-at-the-american-association-for-cancer-research-aacr-annual-meeting-ii","status":"publish","type":"press-release","link":"https:\/\/grail.com\/press-releases\/grail-to-present-new-data-supporting-its-multi-cancer-early-detection-test-at-the-american-association-for-cancer-research-aacr-annual-meeting-ii\/","title":{"rendered":"GRAIL to Present New Data Supporting its Multi-Cancer Early Detection Test at the American Association for Cancer Research (AACR) Annual Meeting II"},"content":{"rendered":"

MENLO PARK, Calif., June 22,\u00a02020 \u2014 GRAIL, Inc., a healthcare company whose mission is to detect cancer early, today announced that new data for its investigational multi-cancer early detection blood test will be presented at the American Association for Cancer Research (AACR) Virtual Annual Meeting II.<\/p>\n

Today, the majority of deadly cancers go undetected until they have progressed to late stages, when chances of survival are much lower. This is because most deadly cancers do not have guideline-recommended screening tests available.<\/p>\n

GRAIL\u2019s multi-cancer early detection technology can detect more than 50 cancers, with a very low false positive rate of less than one percent, through a single blood draw. When a cancer signal is detected, the test also identifies where the cancer is located in the body (the tissue of origin) with high accuracy.<\/p>\n

\u201cAt GRAIL, we believe that in order to bend the curve on cancer mortality, we need to transition from screening only for individual cancers, to screening individuals for all types of cancers,\u201d said Joshua Ofman, MD, MSHS, Chief Medical Officer and External Affairs at GRAIL. \u201cThese new data demonstrate our continued commitment to scientific rigor, and further support the use of our multi-cancer early detection test in broad populations.\u201d<\/p>\n

GRAIL\u2019s multi-cancer early detection test is supported by evidence from its population-scale clinical study program, which is believed to be the largest ever conducted in genomic medicine.<\/p>\n

The AACR presentation details are included below. The slides and recordings will be available on\u00a0www.grail.com<\/a>\u00a0at the conclusion of the meeting.<\/p>\n

AACR Presentation Details<\/b><\/p>\n

Abstract 2308\/19
\nJoerg Bredno, et al. Classifier performance of a cfDNA-based multi-cancer detection test on uncommon cancer types
\n<\/i>Session PO.PR02.02 \u2014 Clinical Prevention, Early Detection, and Interception 2: June 22, 2020: 9:00AM-6:00PM EDT<\/p>\n

Abstract 721\/15
\nGregory Alexander, et al. Analytical validation of a multi-cancer early detection test with tissue localization using a cell-free DNA-based targeted methylation assay
\n<\/i>Session PO.CL11.08 \u2014 Circulating Markers 1: June 22, 2020: 9:00AM-6:00PM EDT<\/p>\n

Abstract 2114\/1
\nRobert Calef, et al. HPV-driven cancers show distinct methylation signatures in cell-free DNA (cfDNA)
\n<\/i>Session PO.BSB01.05 \u2014 Multi-omic and Multimodal Discovery: June 22, 2020: 9:00AM-6:00PM EDT<\/p>\n

Abstract 139\/2
\nQinwen Liu, et al. cfDNA methylation profiling distinguishes lineage-specific hematologic malignancies
\n<\/i>Session PO.MCB05.01\u2014 DNA Methylation: June 22, 2020: 9:00AM-6:00PM EDT<\/p>\n

About GRAIL\u2019s Multi-Cancer Early Detection Test<\/b><\/p>\n

GRAIL\u2019s multi-cancer early detection blood test can detect more than 50 cancers, across all stages, with a very low false positive rate of less than one percent, through a single blood draw. When a cancer signal is detected, the test identifies where in the body the cancer is located with high accuracy, an important step to guiding diagnostic next steps and care.<\/p>\n

About GRAIL<\/b><\/p>\n

GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by developing pioneering technology to detect and identify multiple deadly cancer types early. The company is using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art computer science and data science to enhance the scientific understanding of cancer biology, and to develop its multi-cancer early detection blood test. GRAIL is headquartered in Menlo Park, CA with locations in Washington, D.C., North Carolina, and the United Kingdom. It is supported by leading global investors and pharmaceutical, technology, and healthcare companies. For more information, please visit www.grail.com.<\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

MENLO PARK, Calif., June 22,\u00a02020 \u2014 GRAIL, Inc., a healthcare company whose mission is to detect cancer early, today announced that new data for its investigational multi-cancer early detection blood test will be presented at the American Association for Cancer Research (AACR) Virtual Annual Meeting II. Today, the majority of deadly cancers go undetected until […]<\/p>\n","protected":false},"featured_media":1306,"parent":0,"menu_order":0,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-1446","press-release","type-press-release","status-publish","format-standard","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"\nGRAIL to Present New Data Supporting its Multi-Cancer Early Detection Test at the American Association for Cancer Research (AACR) Annual Meeting II - GRAIL<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/grail.com\/press-releases\/grail-to-present-new-data-supporting-its-multi-cancer-early-detection-test-at-the-american-association-for-cancer-research-aacr-annual-meeting-ii\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GRAIL to Present New Data Supporting its Multi-Cancer Early Detection Test at the American Association for Cancer Research (AACR) Annual Meeting II - GRAIL\" \/>\n<meta property=\"og:description\" content=\"MENLO PARK, Calif., June 22,\u00a02020 \u2014 GRAIL, Inc., a healthcare company whose mission is to detect cancer early, today announced that new data for its investigational multi-cancer early detection blood test will be presented at the American Association for Cancer Research (AACR) Virtual Annual Meeting II. Today, the majority of deadly cancers go undetected until […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/grail.com\/press-releases\/grail-to-present-new-data-supporting-its-multi-cancer-early-detection-test-at-the-american-association-for-cancer-research-aacr-annual-meeting-ii\/\" \/>\n<meta property=\"og:site_name\" content=\"GRAIL\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/grailbio\/\" \/>\n<meta property=\"article:modified_time\" content=\"2021-01-12T17:57:23+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/grail.com\/wp-content\/uploads\/2020\/12\/images@2x.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"423\" \/>\n\t<meta property=\"og:image:height\" content=\"172\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@grailbio\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/grail.com\/press-releases\/grail-to-present-new-data-supporting-its-multi-cancer-early-detection-test-at-the-american-association-for-cancer-research-aacr-annual-meeting-ii\/\",\"url\":\"https:\/\/grail.com\/press-releases\/grail-to-present-new-data-supporting-its-multi-cancer-early-detection-test-at-the-american-association-for-cancer-research-aacr-annual-meeting-ii\/\",\"name\":\"GRAIL to Present New Data Supporting its Multi-Cancer Early Detection Test at the American Association for Cancer Research (AACR) Annual Meeting II - GRAIL\",\"isPartOf\":{\"@id\":\"https:\/\/grail.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/grail.com\/press-releases\/grail-to-present-new-data-supporting-its-multi-cancer-early-detection-test-at-the-american-association-for-cancer-research-aacr-annual-meeting-ii\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/grail.com\/press-releases\/grail-to-present-new-data-supporting-its-multi-cancer-early-detection-test-at-the-american-association-for-cancer-research-aacr-annual-meeting-ii\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/assets.grail.com\/wp-content\/uploads\/2020\/12\/images%402x.jpg\",\"datePublished\":\"2020-06-22T21:42:10+00:00\",\"dateModified\":\"2021-01-12T17:57:23+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/grail.com\/press-releases\/grail-to-present-new-data-supporting-its-multi-cancer-early-detection-test-at-the-american-association-for-cancer-research-aacr-annual-meeting-ii\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/grail.com\/press-releases\/grail-to-present-new-data-supporting-its-multi-cancer-early-detection-test-at-the-american-association-for-cancer-research-aacr-annual-meeting-ii\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/grail.com\/press-releases\/grail-to-present-new-data-supporting-its-multi-cancer-early-detection-test-at-the-american-association-for-cancer-research-aacr-annual-meeting-ii\/#primaryimage\",\"url\":\"https:\/\/assets.grail.com\/wp-content\/uploads\/2020\/12\/images%402x.jpg\",\"contentUrl\":\"https:\/\/assets.grail.com\/wp-content\/uploads\/2020\/12\/images%402x.jpg\",\"width\":423,\"height\":172},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/grail.com\/press-releases\/grail-to-present-new-data-supporting-its-multi-cancer-early-detection-test-at-the-american-association-for-cancer-research-aacr-annual-meeting-ii\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/grail.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GRAIL to Present New Data Supporting its Multi-Cancer Early Detection Test at the American Association for Cancer Research (AACR) Annual Meeting II\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/grail.com\/#website\",\"url\":\"https:\/\/grail.com\/\",\"name\":\"GRAIL\",\"description\":\"Detect cancer early, when it can be cured\",\"publisher\":{\"@id\":\"https:\/\/grail.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/grail.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/grail.com\/#organization\",\"name\":\"GRAIL, LLC\",\"url\":\"https:\/\/grail.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/grail.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/assets.grail.com\/wp-content\/uploads\/2021\/01\/cropped-favicon-G.png\",\"contentUrl\":\"https:\/\/assets.grail.com\/wp-content\/uploads\/2021\/01\/cropped-favicon-G.png\",\"width\":512,\"height\":512,\"caption\":\"GRAIL, LLC\"},\"image\":{\"@id\":\"https:\/\/grail.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/grailbio\/\",\"https:\/\/x.com\/grailbio\",\"https:\/\/www.linkedin.com\/company\/grail-inc.\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GRAIL to Present New Data Supporting its Multi-Cancer Early Detection Test at the American Association for Cancer Research (AACR) Annual Meeting II - GRAIL","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/grail.com\/press-releases\/grail-to-present-new-data-supporting-its-multi-cancer-early-detection-test-at-the-american-association-for-cancer-research-aacr-annual-meeting-ii\/","og_locale":"en_US","og_type":"article","og_title":"GRAIL to Present New Data Supporting its Multi-Cancer Early Detection Test at the American Association for Cancer Research (AACR) Annual Meeting II - GRAIL","og_description":"MENLO PARK, Calif., June 22,\u00a02020 \u2014 GRAIL, Inc., a healthcare company whose mission is to detect cancer early, today announced that new data for its investigational multi-cancer early detection blood test will be presented at the American Association for Cancer Research (AACR) Virtual Annual Meeting II. Today, the majority of deadly cancers go undetected until […]","og_url":"https:\/\/grail.com\/press-releases\/grail-to-present-new-data-supporting-its-multi-cancer-early-detection-test-at-the-american-association-for-cancer-research-aacr-annual-meeting-ii\/","og_site_name":"GRAIL","article_publisher":"https:\/\/www.facebook.com\/grailbio\/","article_modified_time":"2021-01-12T17:57:23+00:00","og_image":[{"width":423,"height":172,"url":"http:\/\/grail.com\/wp-content\/uploads\/2020\/12\/images@2x.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@grailbio","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/grail.com\/press-releases\/grail-to-present-new-data-supporting-its-multi-cancer-early-detection-test-at-the-american-association-for-cancer-research-aacr-annual-meeting-ii\/","url":"https:\/\/grail.com\/press-releases\/grail-to-present-new-data-supporting-its-multi-cancer-early-detection-test-at-the-american-association-for-cancer-research-aacr-annual-meeting-ii\/","name":"GRAIL to Present New Data Supporting its Multi-Cancer Early Detection Test at the American Association for Cancer Research (AACR) Annual Meeting II - GRAIL","isPartOf":{"@id":"https:\/\/grail.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/grail.com\/press-releases\/grail-to-present-new-data-supporting-its-multi-cancer-early-detection-test-at-the-american-association-for-cancer-research-aacr-annual-meeting-ii\/#primaryimage"},"image":{"@id":"https:\/\/grail.com\/press-releases\/grail-to-present-new-data-supporting-its-multi-cancer-early-detection-test-at-the-american-association-for-cancer-research-aacr-annual-meeting-ii\/#primaryimage"},"thumbnailUrl":"https:\/\/assets.grail.com\/wp-content\/uploads\/2020\/12\/images%402x.jpg","datePublished":"2020-06-22T21:42:10+00:00","dateModified":"2021-01-12T17:57:23+00:00","breadcrumb":{"@id":"https:\/\/grail.com\/press-releases\/grail-to-present-new-data-supporting-its-multi-cancer-early-detection-test-at-the-american-association-for-cancer-research-aacr-annual-meeting-ii\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/grail.com\/press-releases\/grail-to-present-new-data-supporting-its-multi-cancer-early-detection-test-at-the-american-association-for-cancer-research-aacr-annual-meeting-ii\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/grail.com\/press-releases\/grail-to-present-new-data-supporting-its-multi-cancer-early-detection-test-at-the-american-association-for-cancer-research-aacr-annual-meeting-ii\/#primaryimage","url":"https:\/\/assets.grail.com\/wp-content\/uploads\/2020\/12\/images%402x.jpg","contentUrl":"https:\/\/assets.grail.com\/wp-content\/uploads\/2020\/12\/images%402x.jpg","width":423,"height":172},{"@type":"BreadcrumbList","@id":"https:\/\/grail.com\/press-releases\/grail-to-present-new-data-supporting-its-multi-cancer-early-detection-test-at-the-american-association-for-cancer-research-aacr-annual-meeting-ii\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/grail.com\/"},{"@type":"ListItem","position":2,"name":"GRAIL to Present New Data Supporting its Multi-Cancer Early Detection Test at the American Association for Cancer Research (AACR) Annual Meeting II"}]},{"@type":"WebSite","@id":"https:\/\/grail.com\/#website","url":"https:\/\/grail.com\/","name":"GRAIL","description":"Detect cancer early, when it can be cured","publisher":{"@id":"https:\/\/grail.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/grail.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/grail.com\/#organization","name":"GRAIL, LLC","url":"https:\/\/grail.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/grail.com\/#\/schema\/logo\/image\/","url":"https:\/\/assets.grail.com\/wp-content\/uploads\/2021\/01\/cropped-favicon-G.png","contentUrl":"https:\/\/assets.grail.com\/wp-content\/uploads\/2021\/01\/cropped-favicon-G.png","width":512,"height":512,"caption":"GRAIL, LLC"},"image":{"@id":"https:\/\/grail.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/grailbio\/","https:\/\/x.com\/grailbio","https:\/\/www.linkedin.com\/company\/grail-inc.\/"]}]}},"_links":{"self":[{"href":"https:\/\/grail.com\/wp-json\/wp\/v2\/press-release\/1446","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/grail.com\/wp-json\/wp\/v2\/press-release"}],"about":[{"href":"https:\/\/grail.com\/wp-json\/wp\/v2\/types\/press-release"}],"version-history":[{"count":0,"href":"https:\/\/grail.com\/wp-json\/wp\/v2\/press-release\/1446\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/grail.com\/wp-json\/wp\/v2\/media\/1306"}],"wp:attachment":[{"href":"https:\/\/grail.com\/wp-json\/wp\/v2\/media?parent=1446"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}